231 related articles for article (PubMed ID: 7718002)
21. C1 activation and dissociation in disease.
Laurell AB; Mårtensson U; Sjöholm AG
Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
[TBL] [Abstract][Full Text] [Related]
22. C1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins.
Cai Y; Teo BH; Yeo JG; Lu J
J Biol Chem; 2015 Sep; 290(37):22570-80. PubMed ID: 26231209
[TBL] [Abstract][Full Text] [Related]
23. C1r-C1s-C1inhibitor (C1rs-C1inh) complex measurements in tears of patients before and after penetrating keratoplasty.
Kerényi A; Nagy G; Veres A; Varga L; Füst A; Nagymihány A; Czumbel N; Süveges I; Füst G
Curr Eye Res; 2002 Feb; 24(2):99-104. PubMed ID: 12187480
[TBL] [Abstract][Full Text] [Related]
24. Structure of the C1r-C1s interaction of the C1 complex of complement activation.
Almitairi JOM; Venkatraman Girija U; Furze CM; Simpson-Gray X; Badakshi F; Marshall JE; Schwaeble WJ; Mitchell DA; Moody PCE; Wallis R
Proc Natl Acad Sci U S A; 2018 Jan; 115(4):768-773. PubMed ID: 29311313
[TBL] [Abstract][Full Text] [Related]
25. Binding of purified C1 subcomponents, C1 inactivator and their complexes to immobilized heparin.
McKay EJ; Johnson U; Laurell AB; Mårtensson U; Sjöholm AG
Acta Pathol Microbiol Scand C; 1981 Oct; 89(5):339-44. PubMed ID: 6274149
[TBL] [Abstract][Full Text] [Related]
26. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
Bauer J; Valet G
Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
[TBL] [Abstract][Full Text] [Related]
27. The cleavage of two C1s subunits by a single active C1r reveals substantial flexibility of the C1s-C1r-C1r-C1s tetramer in the C1 complex.
Lörincz Z; Gál P; Dobó J; Cseh S; Szilágyi K; Ambrus G; Závodszky P
J Immunol; 2000 Aug; 165(4):2048-51. PubMed ID: 10925288
[TBL] [Abstract][Full Text] [Related]
28. Complement activation, circulating C1q binding substances and inflammatory activity in rheumatoid arthritis: relations and changes on suppression of inflammation.
Berglund K; Laurell AB; Nived O; Sjoholm AG; Sturfelt G
J Clin Lab Immunol; 1980 Jul; 4(1):7-14. PubMed ID: 7463476
[TBL] [Abstract][Full Text] [Related]
29. Structural basis of the C1q/C1s interaction and its central role in assembly of the C1 complex of complement activation.
Venkatraman Girija U; Gingras AR; Marshall JE; Panchal R; Sheikh MA; Harper JA; Gál P; Schwaeble WJ; Mitchell DA; Moody PC; Wallis R
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13916-20. PubMed ID: 23922389
[TBL] [Abstract][Full Text] [Related]
30. Serum levels of C1 subunits in rheumatoid arthritis.
Rosano CL; Parhami N; Hurwitz C
J Lab Clin Med; 1984 Feb; 103(2):313-21. PubMed ID: 6319517
[TBL] [Abstract][Full Text] [Related]
31. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
Laurell AB; Mårtensson U; Sjöholm AG
J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
[TBL] [Abstract][Full Text] [Related]
32. Mapping surface accessibility of the C1r/C1s tetramer by chemical modification and mass spectrometry provides new insights into assembly of the human C1 complex.
Brier S; Pflieger D; Le Mignon M; Bally I; Gaboriaud C; Arlaud GJ; Daniel R
J Biol Chem; 2010 Oct; 285(42):32251-63. PubMed ID: 20592021
[TBL] [Abstract][Full Text] [Related]
33. C1 activation, with C1q in excess of functional C1 in synovial fluid from patients with rheumatoid arthritis.
Sjöholm AG; Berglund K; Johnson U; Laurell AB; Sturfelt G
Int Arch Allergy Appl Immunol; 1986; 79(2):113-9. PubMed ID: 3484727
[TBL] [Abstract][Full Text] [Related]
34. Measurement of macromolecular interactions between complement subcomponents C1q, C1r, C1s, and immunoglobulin IgM by sedimentation analysis using the analytical ultracentrifuge.
Poon PH; Schumaker VN
J Biol Chem; 1991 Mar; 266(9):5723-7. PubMed ID: 2005109
[TBL] [Abstract][Full Text] [Related]
35. Analysis of human C1q by combined bottom-up and top-down mass spectrometry: detailed mapping of post-translational modifications and insights into the C1r/C1s binding sites.
Pflieger D; Przybylski C; Gonnet F; Le Caer JP; Lunardi T; Arlaud GJ; Daniel R
Mol Cell Proteomics; 2010 Apr; 9(4):593-610. PubMed ID: 20008834
[TBL] [Abstract][Full Text] [Related]
36. Atypical hypocomplementemic vasculitis syndrome in a child.
Waldo FB; Leist PA; Strife CF; Forristal J; West CD
J Pediatr; 1985 May; 106(5):745-50. PubMed ID: 2987470
[TBL] [Abstract][Full Text] [Related]
37. Complement C1q Interacts With LRP1 Clusters II and IV Through a Site Close but Different From the Binding Site of Its C1r and C1s-Associated Proteases.
Fouët G; Gout E; Wicker-Planquart C; Bally I; De Nardis C; Dedieu S; Chouquet A; Gaboriaud C; Thielens NM; Kleman JP; Rossi V
Front Immunol; 2020; 11():583754. PubMed ID: 33193398
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.
van den Berg RH; Faber-Krol MC; van de Klundert JA; van Es LA; Daha MR
J Immunol; 1996 Jun; 156(11):4466-73. PubMed ID: 8666822
[TBL] [Abstract][Full Text] [Related]
39. Electron microscope studies of C1s, C1s2, C1r2, C1r2C1s2 and C1-inhibitor.
Schumaker VN; Phillips ML
Behring Inst Mitt; 1993 Dec; (93):17-24. PubMed ID: 8172564
[No Abstract] [Full Text] [Related]
40. Pathogenesis and laboratory diagnosis of hereditary angioedema.
Zuraw BL; Christiansen SC
Allergy Asthma Proc; 2009; 30(5):487-92. PubMed ID: 19843402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
